Imprivata Rated Strong Positive in Enterprise Single Sign-On Marketscope Report

LEXINGTON, MA — October 6, 2011 —Imprivata® the #1 independent single sign-on (SSO) and access management provider for healthcare and other regulated industries, today announced that it has received a Strong Positive rating in Gartner’s report entitled, MarketScope For Enterprise Single Sign-on1. Strong Positive is the highest possible Marketscope rating and a vendor rated as such is viewed to be a provider of strategic products, services or solutions. Gartner advises current customers to continue with planned investments, and potential customers to consider a vendor in this category as a strong choice for strategic investments.

According to Gartner’s report entitled, Single Sign-On and the Real-Time Healthcare System2, “the requirements and demands of the Real Time Health System are opening up new opportunities for SSO vendors in healthcare — particularly in the areas of shared workstation support, seamless roaming and workflow.” Imprivata’s No Click Access® has set it apart from other solutions, especially in healthcare where it has become the de facto standard for simplifying clinician workflows required for the adoption electronic health records (EHR). “The objective analysis and findings in the Gartner SSO Marketscope, and Imprivata’s Strong Positive rating, reflect what we believe our customers experience: Imprivata OneSign is the foundation for highly-efficient electronic workflows optimized by fast and simplified access to critical data such as protected health information”, commented Ed Gaudet, Chief Marketing Officer at Imprivata.

Imprivata OneSign® is an identity and access management platform that integrates user authentication, user access, password management and aggregated audit data in one secure and easy-to-manage appliance. Access control is simplified with centrally managed authentication and access policies that integrate physical and IT security across your entire organization, around the globe.

About the MarketScope
The MarketScope is copyrighted 2011 by Gartner, Inc. and is reused with permission. The MarketScope is an evaluation of a marketplace at and for a specific time period. It depicts Gartner's analysis of how certain vendors measure against criteria for that marketplace, as defined by Gartner. Gartner does not endorse any vendor, product or service depicted in the MarketScope, and does not advise technology users to select only those vendors with the highest rating. Gartner disclaims all warranties, express or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Imprivata
With more than one million healthcare users, Imprivata is the #1 independent provider of single sign-on and access management solutions for healthcare, government, finance and other regulated industries. By strengthening user authentication, streamlining application access and simplifying compliance reporting across multiple computing environments, customers realize improved workflows, increased security and compliance with government regulations.

Imprivata has received numerous product awards and top review ratings from leading industry publications and analysts, including a Strong Positive rating in Gartner’s 2010 and 2011 ESSO Marketscopes, the #1 ranking in the KLAS SSO Performance report and the #1 rating in 2010 Best in KLAS and Category Leaders report. Headquartered in Lexington, Mass., Imprivata partners with over 200 resellers, and serves the access security needs of more than 1,300 customers around the world. For more information, please visit or follow us on Twitter at @Imprivata.

All Imprivata products are trademarks of Imprivata, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners.

Jennifer Ryan
Imprivata, Inc.

1 Gartner, Inc., “MarketScope for Enterprise Single Sign-On” by G. Kreizman. September 2011
2 Gartner, Inc., “Single Sign-on and the Real Time Health System” by Barry Runyon. October 2010